 |
1A1M |
MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 |
C |
A |
MHC antigen-recognition domain |
|
 |
1A1N |
MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 |
C |
A |
MHC antigen-recognition domain |
|
 |
1A1O |
MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM |
C |
A |
MHC antigen-recognition domain |
|
 |
1IAK |
HISTOCOMPATIBILITY ANTIGEN I-AK |
P |
AB |
MHC antigen-recognition domain |
|
 |
1JF1 |
Crystal structure of HLA-A2*0201 in complex with a decameric altered peptide ligand from the MART-1/Melan-A |
C |
A |
MHC antigen-recognition domain |
|
 |
1JHT |
Crystal structure of HLA-A2*0201 in complex with a nonameric altered peptide ligand (ALGIGILTV) from the MART-1/Melan-A. |
C |
A |
MHC antigen-recognition domain |
|
 |
1RJY |
Mhc Class I Natural Mutant H-2Kbm8 Heavy Chain Complexed With beta-2 Microglobulin and Herpes Simplex Virus Glycoprotein B Peptide |
P |
A |
MHC antigen-recognition domain |
|
 |
1RK1 |
Mhc Class I Natural H-2Kb Heavy Chain Complexed With beta-2 Microglobulin and Herpes Simplex Virus Mutant Glycoprotein B Peptide |
P |
A |
MHC antigen-recognition domain |
|
 |
1S8D |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-3A |
C |
A |
MHC antigen-recognition domain |
|
 |
1SYS |
Crystal structure of HLA, B*4403, and peptide EEPTVIKKY |
C |
A |
MHC antigen-recognition domain |
|
 |
1SYV |
HLA-B*4405 complexed to the dominant self ligand EEFGRAYGF |
C |
A |
MHC antigen-recognition domain |
|
 |
1T1W |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-3F6I8V |
C |
A |
MHC antigen-recognition domain |
|
 |
1T1X |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-4L |
C |
A |
MHC antigen-recognition domain |
|
 |
1T1Y |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-5V |
C |
A |
MHC antigen-recognition domain |
|
 |
1T1Z |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6A |
C |
A |
MHC antigen-recognition domain |
|
 |
1T20 |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6I |
C |
A |
MHC antigen-recognition domain |
|
 |
1T21 |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9, monoclinic crystal |
C |
A |
MHC antigen-recognition domain |
|
 |
1T22 |
Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9, orthorhombic crystal |
C |
A |
MHC antigen-recognition domain |
|
 |
1VGK |
The crystal structure of class I Major histocompatibility complex, H-2Kd at 2.0 A resolution |
C |
A |
MHC antigen-recognition domain |
|
 |
1W0V |
CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 |
C |
A |
MHC antigen-recognition domain |
|
 |
1W0W |
CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 |
C |
A |
MHC antigen-recognition domain |
|
 |
1XR8 |
Crystal Structures of HLA-B*1501 in Complex with Peptides from Human UbcH6 and Epstein-Barr Virus EBNA-3 |
C |
A |
MHC antigen-recognition domain |
|
 |
1XR9 |
Crystal Structures of HLA-B*1501 in Complex with Peptides from Human UbcH6 and Epstein-Barr Virus EBNA-3 |
C |
A |
MHC antigen-recognition domain |
|
 |
2AV1 |
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the E63Q and K66A mutations in the heavy chain. |
C |
A |
MHC antigen-recognition domain |
|
 |
2AV7 |
Crystal structure of HTLV-1 TAX peptide Bound to Human Class I MHC HLA-A2 with the K66A mutation in the heavy chain. |
C |
A |
MHC antigen-recognition domain |
|
 |
2BSR |
CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
C |
A |
MHC antigen-recognition domain |
|
 |
2BST |
CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 |
C |
A |
MHC antigen-recognition domain |
|
 |
2BVO |
STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION |
C |
A |
MHC antigen-recognition domain |
|
 |
2BVP |
STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION |
C |
A |
MHC antigen-recognition domain |
|
 |
2BVQ |
STRUCTURES OF THREE HIV-1 HLA-B5703-PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG-TERM NON-PROGRESSION |
C |
A |
MHC antigen-recognition domain |
|
 |
2C7U |
CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. |
C |
A |
MHC antigen-recognition domain |
|
 |
2CIK |
INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450. |
C |
A |
MHC antigen-recognition domain |
|
 |
2FZ3 |
The role of T cell receptor alpha genes in directing human MHC restriction |
C |
A |
MHC antigen-recognition domain |
|
 |
2NW3 |
Crystal structure of HLA-B*3508 presenting EBV peptide EPLPQGQLTAY at 1.7A |
C |
A |
MHC antigen-recognition domain |
|
 |
2V2W |
T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT |
C |
A |
MHC antigen-recognition domain |
|
 |
2VLL |
THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
C |
A |
MHC antigen-recognition domain |
|